ENTA - ENANTA PHARMACEUTICALS INC

QQQ $ 474.46 $ -4.66 (-0.97 %)

DIA $ 412.48 $ 0.89 (0.22 %)

SPY $ 560.78 $ -1.34 (-0.24 %)

TLT $ 98.13 $ -0.25 (-0.25 %)

GLD $ 232.75 $ 0.74 (0.32 %)

Previous Close

$ 13.3

Open

$ 13.26

Bid

$ 13.30 x 100

Ask

$ 13.34 x 100

Day's Range

$ 13.12 - $ 13.35

52 Week Range

$ 8.08 - $ 17.80

Volume

62,633

Average Volume

Market Cap

281.81M

Beta (5Y Monthly)

$ 0.69

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2024	06-30-2024	10-Q
2	05-08-2024	03-31-2024	10-Q
3	02-08-2024	12-31-2023	10-Q
4	11-22-2023	09-30-2023	10-K
5	08-08-2023	06-30-2023	10-Q
6	05-09-2023	03-31-2023	10-Q
7	02-08-2023	12-31-2022	10-Q
8	11-23-2022	09-30-2022	10-K
9	08-08-2022	06-30-2022	10-Q
10	05-09-2022	03-31-2022	10-Q
11	02-10-2022	12-31-2021	10-Q
12	11-24-2021	09-30-2021	10-K
13	08-09-2021	06-30-2021	10-Q
14	05-10-2021	03-31-2021	10-Q
15	02-09-2021	12-31-2020	10-Q
16	11-25-2020	09-30-2020	10-K
17	08-10-2020	06-30-2020	10-Q
18	05-11-2020	03-31-2020	10-Q
19	02-10-2020	12-31-2019	10-Q
20	11-27-2019	09-30-2019	10-K
21	08-09-2019	06-30-2019	10-Q
22	05-10-2019	03-31-2019	10-Q
23	02-08-2019	12-31-2018	10-Q
24	11-29-2018	09-30-2018	10-K
25	08-09-2018	06-30-2018	10-Q
26	05-10-2018	03-31-2018	10-Q
27	02-09-2018	12-31-2017	10-Q
28	12-11-2017	09-30-2017	10-K
29	08-09-2017	06-30-2017	10-Q
30	05-10-2017	03-31-2017	10-Q
31	02-09-2017	12-31-2016	10-Q
32	12-09-2016	09-30-2016	10-K
33	08-09-2016	06-30-2016	10-Q
34	05-10-2016	03-31-2016	10-Q
35	02-09-2016	12-31-2015	10-Q
36	12-11-2015	09-30-2015	10-K
37	08-10-2015	06-30-2015	10-Q
38	05-08-2015	03-31-2015	10-Q
39	02-06-2015	12-31-2014	10-Q
40	12-11-2014	09-30-2014	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

JP Morgan Maintains Underweight on Enanta ...
08/06/2024 16:18:35

JP Morgan analyst Eric Joseph maintains Enanta Pharma (NASDAQ:ENTA) with a Underweight and lowers the price target from $11 ...

HC Wainwright & Co. Reiterates Buy on Enan...
08/06/2024 10:39:06

HC Wainwright & Co. analyst Ed Arce reiterates Enanta Pharma (NASDAQ:ENTA) with a Buy and maintains $27 price target.

Enanta Pharma Q3 2024 Adj EPS $(1.07) Beat...
08/05/2024 20:18:44

Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(1.07) per share which beat the analyst consensus estimate of $(1.45)...

HC Wainwright & Co. Maintains Buy on Enant...
05/07/2024 17:47:42

HC Wainwright & Co. analyst Ed Arce maintains Enanta Pharma (NASDAQ:ENTA) with a Buy and lowers the price target from $2...

JMP Securities Maintains Market Outperform...
05/07/2024 15:34:16

JMP Securities analyst Roy Buchanan maintains Enanta Pharma (NASDAQ:ENTA) with a Market Outperform and lowers the price targ...

Enanta Pharma Q2 2024 GAAP EPS $(1.47) Mis...
05/06/2024 20:05:27

Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(1.47) per share which missed the analyst consensus estimate of $(1.3...

JP Morgan Maintains Underweight on Enanta ...
02/08/2024 21:43:44

JP Morgan analyst Eric Joseph maintains Enanta Pharma (NASDAQ:ENTA) with a Underweight and lowers the price target from $12 ...

Recap: Enanta Pharma Q1 Earnings
02/07/2024 21:15:14

Enanta Pharma Q1 2024 GAAP EPS $(1.58) Mis...
02/07/2024 21:14:41

Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(1.58) per share which missed the analyst consensus estimate of $(1.2...

Earnings Scheduled For February 7, 2024
02/07/2024 10:13:28

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per shar...

Earnings Preview For Enanta Pharma
02/06/2024 18:02:16

Enanta Pharmaceuticals Will Provide An Upd...
01/04/2024 12:07:18

Expansion into Immunology with New Discovery Program of Oral KIT Inhibitors Addressing High Unmet Need in Chronic Spontaneous...

Oppenheimer Maintains Perform on Enanta Ph...
11/22/2023 18:47:48

Oppenheimer analyst Jay Olson maintains Enanta Pharma (NASDAQ:ENTA) with a Perform and lowers the price target from $25 to $21.

Why American Eagle Shares Are Trading Lowe...
11/21/2023 18:28:06

Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarte...

What 5 Analyst Ratings Have To Say About E...
11/21/2023 14:00:18

HC Wainwright & Co. Maintains Buy on Enant...
11/21/2023 11:53:17

HC Wainwright & Co. analyst Ed Arce maintains Enanta Pharma (NASDAQ:ENTA) with a Buy and lowers the price target from $3...

JMP Securities Maintains Outperform on Ena...
11/21/2023 11:51:14

JMP Securities analyst Roy Buchanan maintains Enanta Pharma (NASDAQ:ENTA) with a Outperform and lowers the price target from...

Recap: Enanta Pharma Q4 Earnings
11/20/2023 21:15:18

Enanta Pharma Q4 EPS $(1.33) Vs. $(1.27) L...
11/20/2023 21:03:39

Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(1.33) per share. This is a 4.72 percent decrease over losses of $(1....

Earnings Scheduled For November 20, 2023
11/20/2023 12:11:31

Companies Reporting Before The Bell • Greenland Technologies (NASDAQ:GTEC) is projected to report quarterly earnings at $0.05 ...